JW (Cayman) Therapeutics (JWCTF) Q3 2025 Earnings

27AugConfirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-0.13
-0.11
-0.1
-0.08

Details

Expected EPS
N/A
Actual EPS
-0.089312
Surprise EPS
-0.09
Surprise Percent
+∞%

Description

JW (Cayman) Therapeutics (JWCTF) has reported earnings of -0.089312 per share for Q3 2025.

0 Comments

Share your thoughts